LT
AZN icon

Legacy Trust’s AstraZeneca AZN Stock Holding History

Legacy Trust’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$294K Buy
+1,574
New +$262K 0.05% 187

Other funds holding AZN

Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return
SEB Asset Management
SEB Asset Management Stockholm $27B AUM
LBP AM
LBP AM Paris, France $11.2B AUM 34.48% 1-Year Est. Return
M&G plc
M&G plc London, United Kingdom $19.9B AUM 15.09% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Legacy Trust's AZN Position: Q3 2026 in Review

Legacy Trust opened a new position in AstraZeneca (AZN) in Q3 2026: 1,574 shares worth $294K. The stake represents 0.05% of the portfolio and ranks #187 among its holdings.

844 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Legacy Trust held 1,574 shares of AstraZeneca worth $294K as of Q3 2026.
  • AstraZeneca was a new Legacy Trust position in Q3 2026.
  • AstraZeneca made up 0.05% of Legacy Trust's portfolio in Q3 2026, its #187 holding.
  • 844 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Legacy Trust's 13F filing for Q3 2026, filed 6 Nov 2026.